Sofinnova Partners Invests in SafeHeal

PARIS – Dechert LLP advised Sofinnova Partners on its investment in SafeHeal, a medtech company specializing in digestive surgery, for a total amount of EUR 6 million.

SafeHeal developed an innovative digestive anastomosis protection device called Colovac that is designed to reduce complications and obviate the need for ostomies for colectomy patients. 

The funds raised will enable the execution of SafeHeal’s clinical and regulatory market access program, followed by a focused commercial launch.

The Paris-based Dechert corporate team advising Sofinnova Partners was led by Anne-Charlotte Rivière with assistance from Thomas Bermudes.

SafeHeal was advised by Beylouni Carbasse Guény Valot Vernet, with Hervé De Kervasdoue and Jérôme Albertin.

About Dechert 

Dechert is a global law firm focused on sectors with the greatest complexities and highest regulatory demands. We deliver practical commercial insight and judgment to our clients' most important matters. Nothing stands in the way of giving clients the best of the firm's entrepreneurial energy and seamless collaboration in a way that is distinctively Dechert.  

Read the press release in French (PDF): Dechert conseille Sofinnova Partners dans le cadre de son investissement dans SafeHeal